##plugins.themes.bootstrap3.article.main##

Background: COVID-19-induced hyponatremia is reportedly associated with pulmonary dysfunction, but mostly among Caucasians. Hence, the current study evaluated sodium status and its correlation with indices of pulmonary dysfunctions among Nigerians of Negroid race.

Methods: This was a retrospectively-designed observational study. Data, all obtained at presentation, were acquired from medical records of 480 RT-PCR-confirmed COVID-19 patients managed at a COVID-19-designated treatment facility in Port Harcourt, Southern Nigeria. Analysis of acquired data was done by COVID-19 clinical grades and sodium status using descriptive and inferential statistics.

Results: At presentation, hyponatremia and hypernatremia were observed in 47.7% and 1.0% of the entire studied cohorts (n=480), respectively. Both disorders (hyponatremia/hypernatremia) were mostly observed among the moderate, severe, and critical cases. Most hyponatremic cases (n=154;67.2%) and the entire hypernatremic cases (n=5;100%) were of mild grades. Hyponatremics had higher proportions of fever, breathlessness, confusion, and a higher burden of inflammatory markers which increased with worsening hyponatremic grade. Etiologically, hyponatremia was mostly associated with the syndrome of inappropriate anti-diuretic hormone secretion (SIADH) (n=132;56.7%). Among the hyponatremics, an inverse correlation existed between sodium and respiratory rate (RR), while a correlation existed between sodium and oxygen saturation (SpO2). Compared to mild hyponatremics, the moderate/severe hyponatremics had a greater risk of having RR>30 and SpO2 <95%. 

Conclusion: Hyponatremia, mostly of mild grade, was common among the studied COVID-19 patients and was associated with indices of pulmonary dysfunctions, including disease severity, inflammatory markers, and SIADH. Hence, hyponatremia should be utilized to triage COVID-19 patients at presentation. However, further studies are recommended to verify these findings.

Downloads

Download data is not yet available.

References

  1. Chi WY, Li YD, Huang HC, Chan TE, Chow SY, Su JH, et al. COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection. J Biomed Sci. 2022; 29(1): 1-27
    DOI  |   Google Scholar
  2. Rabaan AA, Smajlović S, Tombuloglu H, Ćordić S, Hajdarević A, Kudić N, et al. SARS-CoV-2 infection and multi-organ system damage: a review. Bosn J Basic Med Sci. 2022.
    DOI  |   Google Scholar
  3. Amadi C, Lawson S, Amadi B, Agbo E. Correlation of plasma albumin status with markers of hepato-biliary dysfunction and Systemic Inflammation Among COVID-19 Patients. Biomed Sci. 2022; 8 (1): 41-48.
    DOI  |   Google Scholar
  4. Amadi C, Lawson S. The Impact of Systemic Inflammation on Sex-based Bias Following SARS-CoV-2 Infection. Eur J Clin Biomed Sci. 2022; 8(1): 1-8
    DOI  |   Google Scholar
  5. Lawson S, Amadi C. Assessment of surrogate markers/indices of inflammation among COVID-19 patients with and without comorbid conditions. Am J Lab Med. 2022; 7(1): 16-22
    DOI  |   Google Scholar
  6. Lawson S, Amadi C. Potentials of varied inflammatory indices in the prediction of COVID-19 severity among Nigerians. Adv Biochem. 2022; 10(1); 18-24.
    DOI  |   Google Scholar
  7. Amadi B, Lawson S, Amadi C. Hypokalemia and Its correlates among Nigerian SARS-CoV-2 infected patients. Biomed Sci. 2022; 8(1); 20-27.
    DOI  |   Google Scholar
  8. Machiraju PK, Alex NM, Safinaaz, Vadamalai V. Hyponatremia in Coronavirus Disease-19 Patients: A Retrospective Analysis. Can J Kidney Health Dis. 2021; 8: 20543581211067069.
    DOI  |   Google Scholar
  9. Atila C, Monnerat S, Bingisser R, Siegemund M, Lampart M, Rueegg M, et al. Inverse relationship between IL-6 and sodium levels in patients with COVID-19 and other respiratory tract infections: data from the COVIVA study. Endocr Connect. 2022; 11(10): e220171.
    DOI  |   Google Scholar
  10. Ayus JC, Negri AL, Moritz ML, Lee KM, Caputo D, Borda ME, et al. Hyponatremia, Inflammation at Admission, and Mortality in Hospitalized COVID-19 Patients: A Prospective Cohort Study. Front Med (Lausanne). 2021; 8: 748364.
    DOI  |   Google Scholar
  11. Islam MK, Hasan P, Sharif MM, Khan TD, Ratul RH, Hossain FS, Molla MMA. Hyponatremia in COVID-19 patients: Experience from Bangladesh. Health Sci Rep. 2022; 5(2): e565.
    DOI  |   Google Scholar
  12. Yousaf Z, Al-Shokri SD, Al-Soub H, Mohamed MFH. COVID-19-associated SIADH: a clue in the times of pandemic!. Am J Physiol Endocrinol Metab. 2020; 318(6): E882-E885.
    DOI  |   Google Scholar
  13. Berni A, Malandrino D, Corona G, Maggi M, Parenti G, Fibbi B, et al. Serum sodium alterations in SARS CoV-2 (COVID-19) infection: impact on patient outcome. Eur J Endocrinol. 2021; 185(1): 137-144.
    DOI  |   Google Scholar
  14. Fajri M, Essafti M, Aloua R, Mouaffak Y. Severe case of COVID -19 pneumonia complicated by SIADH. Ann Med Surg (Lond). 2022; 73: 103153.
    DOI  |   Google Scholar
  15. De Carvalho H, Letellier T, Karakachoff M, Desvaux G, Caillon H, Papuchon E, et al. Hyponatremia is associated with poor outcome in COVID-19. J Nephrol. 2021; 34(4): 991-8.
    DOI  |   Google Scholar
  16. Hu W, Li C, Xu Y, Qi Y, Zhang Z, Li M, Cai F, Liu D, Yue J, Ye M, Chen Q. Disorders of sodium balance and its clinical implications in COVID-19 patients: a multicenter retrospective study. Int Emerg Med. 2021; 16(4): 853-62.
    DOI  |   Google Scholar
  17. Kopel J, Perisetti A, Roghani A, Aziz M, Gajendran M, Goyal H. Racial and Gender-Based Differences in COVID-19. Front Public Health. 2020; 8: 418.
    DOI  |   Google Scholar
  18. Naing L, Winn T, Rusli BN. Practical issues in calculating the sample size for prevalence studies. Arch Orofac Sci. 2006; 1: 9–14.
     Google Scholar
  19. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 Treatment Guidelines. The National Institutes of Health. [Internet] [cited 2022 December 11] Available from: https://www.covid19treatmentguidelines.nih.gov
     Google Scholar
  20. Redant S, Vanderhulst J, Maillart E, Attou R, Gallerani A, Honoré PM, et al. Significance of Hypernatremia Due to SARS-CoV-2 Associated ARDS in Critically Ill Patients. J Transl Int Med. 2020; 8(4): 255-260.
    DOI  |   Google Scholar
  21. Worthley LI, Guerin M, Pain RW. For calculating osmolality, the simplest formula is the best. Anaesth Intensive Care. 1987; 15(2): 199-202.
    DOI  |   Google Scholar
  22. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med. 1999; 106(4): 399-403.
    DOI  |   Google Scholar
  23. Tzoulis P, Waung JA, Bagkeris E, Hussein Z, Biddanda A, Cousins J, et al. Dysnatremia is a Predictor for Morbidity and Mortality in Hospitalized Patients with COVID-19. J Clin Endocrinol Metab. 2021; 106(6): 1637-1648.
    DOI  |   Google Scholar
  24. De Jesus Vidal-Mayo J, Olivas-Martinez A, Perez-Diaz I, Lopez-Navarro JM, Sanchez-Landa E, Carrillo-Maravilla E, et al. Calculated Versus Measured Urine Osmolarity: Accuracy of Estimated Urine Density. Rev Invest Clin. 2018; 70(6): 310-8.
    DOI  |   Google Scholar
  25. Al-Kuraishy HM, Al-Gareeb AI, Qusti S, Alshammari EM, Atanu FO, Batiha GE. Arginine vasopressin and pathophysiology of COVID-19: An innovative perspective. Biomed Pharmacother. 2021; 143: 112193.
    DOI  |   Google Scholar
  26. Berni A, Malandrino D, Parenti G, Maggi M, Poggesi L, Peri A. Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together? J Endocrinol Invest. 2020; 43(8): 1137-1139.
    DOI  |   Google Scholar